- Home
- HRTX vs ACRE Comparison
HRTX vs ACRE Comparison
Compare HRTX & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HRTX | ACRE |
|---|---|---|
| Founded | 1983 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.3M | 254.1M |
| IPO Year | 2007 | 2011 |
Fundamental Metrics
Financial Performance| Metric | HRTX | ACRE |
|---|---|---|
| Price | $0.39 | $4.83 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | $4.50 | ★ $5.38 |
| AVG Volume (30 Days) | ★ 4.1M | 373.4K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 11.58% |
| EPS Growth | N/A | ★ 26.17 |
| EPS | N/A | ★ 1.35 |
| Revenue | ★ $154,904,000.00 | $54,833,000.00 |
| Revenue This Year | $15.28 | N/A |
| Revenue Next Year | $20.29 | $16.28 |
| P/E Ratio | ★ N/A | $3.61 |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $0.38 | $4.05 |
| 52 Week High | $2.30 | $5.89 |
Technical Indicators
Market Signals| Indicator | HRTX | ACRE |
|---|---|---|
| Relative Strength Index (RSI) | 23.14 | 44.99 |
| Support Level | N/A | $4.82 |
| Resistance Level | $1.34 | $5.13 |
| Average True Range (ATR) | 0.06 | 0.11 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 0.83 | 11.67 |
Price Performance
Historical ComparisonAbout HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.